Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma
, , , , , , , und | 03. Dez. 2020
Über diesen Artikel
Article Category: Research Article
Online veröffentlicht: 03. Dez. 2020
Seitenbereich: 66 - 76
Eingereicht: 21. Juli 2020
Akzeptiert: 06. Okt. 2020
DOI: https://doi.org/10.2478/raon-2020-0070
© 2021 Cuimeng Tian, Guimei Liu, Yongxiang Xu, Guangrong Xia, Tongmei Zhang, Jiaqiang Huang, Hui Jiang, Ji Ming Wang, Baolan Li, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Cuimeng Tian
Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Laboratory of Cancer ImmunoMetabolism, Center for Cancer Research, National Cancer Institute at FrederickFrederick, USA
Guimei Liu
Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Yongxiang Xu
Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Guangrong Xia
Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Tongmei Zhang
Department of General Medicine, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Jiaqiang Huang
Department of Cellular and Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Hui Jiang
Division of Technology, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China
Ji Ming Wang
Laboratory of Cancer ImmunoMetabolism, Center for Cancer Research, National Cancer Institute at FrederickFrederick, USA
Baolan Li
Department of General Medicine, Beijing Tuberculosis and Thoracic Tumor Research Institute / Beijing Chest Hospital, Capital Medical UniversityBeijing, China